Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Income Quality Over Time
Above historical average, modest growth trend.
Left:
||||
Quality of reported income
Latest
1.24
↑ 72% above average
Average (9y)
0.72
Historical baseline
Range
High:2.70
Low:-2.27
CAGR
+5.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 1.24 | -6.7% |
| 2023 | 1.33 | +3408.5% |
| 2022 | -0.04 | -107.4% |
| 2021 | 0.54 | -43.0% |
| 2020 | 0.95 | -64.6% |
| 2019 | 2.70 | +309.2% |
| 2018 | 0.66 | -49.6% |
| 2017 | 1.31 | +157.6% |
| 2016 | -2.27 | -396.7% |
| 2015 | 0.77 | - |